“药物研发新时代：数据，预测，人工智能”暨第四届爱思唯尔药物研发论坛
“药物研发新时代：数据，预测，人工智能”暨第四届爱思唯尔药物研发论坛将于2018年10月15日在上海隆重举行。目前论坛前期准备工作基本就绪，我们更新了演讲嘉宾介绍和会议日程，在此向您发出第二轮邀请。
会议组织单位
主办方
联合主办方
媒体合作伙伴
论坛演讲嘉宾介绍
Professor Mark Waller, Physics Department, College of Science, Shanghai University
Mark Waller教授，上海大学教授，物理系东方学者
▼
Professor Mark Waller has 45 scientific publications including Nature, Angewandte Chemie, ACS Central Science, and Chemistry - A European Journal, and over 25 oral presentations in academia and industry. Recently Professor Mark Waller and his team has published in Nature the article of “Planning chemical syntheses with deep neural networks and symbolic AI” (Nature, 555(7698):604-610).
Dr.Rujian Ma,VP & Chief Chemist,head of Chemical Technology Department, New Drug Development Division of WuXi AppTec
马汝建博士，副总裁，首席化学家，化学技术部负责人，药明康德新药开发有限公司
▼
Dr. Rujian MA received his master's degree inorganic chemistry from the Department of Chemistry, East China University of Science and Technology in 1995. He returned to China after obtaining doctor’s degree from Japan, and had joint Wuxi Apptec as one of the earliest researchers in the year 2001. In August 2008, Dr. MA was promoted to Vice President of Chemistry. In March 2018, he was appointed chief chemist to lead the Department of chemical technology. Dr. Ma has strong experience in industrial practical organic synthetic chemistry, especially in the design of organic synthetic routes.
Ms. Xing Li, CEO, Deep Intelligent Pharma
李星女士，深度智耀 首席执行官
▼
Ms. Xing Li is the founder and CEO of Deep Intelligent Pharma. She has worked in the new drug development department of Pfizer, Sanofi, Johnson & Johnson for 12 years with rich experiences. In October 2017, she launched Deep Intelligent Pharma, which aims to empower the entire process of new drug development with state-of-the-art AI technology. Ms. Xing Li had obtained her master's degree in pharmacy from Peking University.
Mr.Gordon Zhang, Sr. Knowledge Management Manager, Novartis
张歌先生，诺华（中国）生物医学研究中心 高级经理
▼
Representing Novartis Knowledge Center (NKC) in Asia from 2010, Mr. Zhang is in charge of supporting Novartis’s internal colleagues’ needs on external intelligence,particularly focusing on providing decision-making reference & report for leadership team. Mr. Zhang has graduated from Fudan University with a MBA degree from the BI-Fudan MBA program and Jilin University with a bachelor degree majored in Chemistry.
Dr. Pierre Morieux,ChemDraw Global Marketing Manager, Perkin Elmer
Pierre Morieux博士，ChemDraw全球市场经理，珀金埃尔默
▼
Pierre Morieux got a Ph.D. in Pharmaceutical Sciences in 2010 from the University of North Carolina at Chapel Hill, and then did a post-doc in bioorganic chemistry at the University of Strasbourg, France. After 4 years spent as a Field Application Scientist, he is now the ChemDraw Global Marketing Manager at PerkinElmer.
Dr. Guozhi Tang, VP of Discovery, Ascentage Pharma
唐国志博士，药物发现副总经理，亚盛医药
▼
Dr. Guozhi Tang joined Ascentage Pharma in 2016 as VP of Discovery to take care of the early stage portfolio and discovery. Prior to that, he was a principle scientist and research investigator at Roche Innovation Center Shanghai (RICS), where he had led various discovery projects to success delivery of 4+ preclinical candidates and clinical-stage drugs in anti-cancer,anti-viral and metabolic disease areas. Gordon has 30+ publications and 12+patents, and he serves as a SAB member of J. Med. Chem.
Mr. NealKatz, Elsevier Life Science Solution Marketing Director
Neal Katz先生，生命科学解决方案市场总监，爱思唯尔
▼
Neal Katz has spent over 20 years focusing on B2B IT solutions in the communications, academic and pharmaceutical industries. He has launched and managed business solutions at several companies including AT&T, Global Crossing, and Intel. Nealjoint Elsevier in 2008. In 2017, he became the Director of Life Science Solutions Marketing. Neal lives in Bridgewater, NJ and has an MBA from the City University of New York.
Dr.Matthew Clark, Director, Scientific Services, Elsevier
Matthew Clark博士,科学服务总监，爱思唯尔
▼
Dr.Matthew Clark is Director of Scientific Services at Elsevier. He has broad experience in pharmaceutical research and development. He has led teams in discovery research in large and small pharmaceutical companies, and in the scientific software and data industries. He is highly published in preclinicaland clinical informatics for pharmaceutical development. Dr. Clark’s team at Elsevier work with leading pharmaceutical companies applying AI/Machine Learning to synthetic chemistry, predictive modeling, and safety pharmacology.
Mr. Genan Zhao, General Manager, Research Solutions, Elsevier China
赵歌喃先生,中国区科技部总经理，爱思唯尔
▼
Genan Zhao is the General Manager of Elsevier’s Research Solutions in China. In his over 20 years in the technology industry, including 15 years at Microsoft, he has been responsible for multiple successful initiatives including product research and development, customer services. He has considerate expertise in assisting corporations in their transition to digital operations. Genan rounds out our panel with a perspective on the informatics technologies that enable modern chemical sciences research.
论坛地点
上海博雅酒店（张江高科），碧波路699号
论坛日程安排
时间
主题
演讲人
8:30-9:00
Registration
签到
9:00-9:10
Opening
开幕致辞
Mr. Genan ZHAO, General Manager, Research Solutions, Elsevier China
赵歌喃先生, 爱思唯尔中国区科技部总经理
9:10-9:50
Learning the Art of Chemical Synthesis with Discipline Scale Data
利用学科大数据探索化学合成之美
Professor Mark Waller, Shanghai University
Mark Waller 教授，上海大学
9:50-10:30
Present Situation and the Prospect of Computer Aided Drug Design
计算机辅助有机合成路线设计现状与展望
Dr. Rujian MA, VP & Chief Chemist, Head of Chemical Technology Department, New Drug Development Division of WuXi AppTec
马汝建博士，药明康德新药开发有限公司 副总裁，首席化学家，化学技术部负责人
10:30-10:45
Q&A Discussion
10:45-11:00
Tea Break 茶歇
11:00-11:40
AI Accelerates New Drug Research and Development
智耀无界，领航研发 – AI加速新药研发
Ms. Xing LI, CEO, Deep Intelligent Pharma
李星女士，深度智耀 首席执行官
11:40-12:20
Turning Big Data into Smart Data: Analytics and the Pharma R&D Ecosystem
化大数据为智数据：分析与医药研发生态系统
Mr. Neal Katz, Life Science Solution Mktg Director, Elsevier
Neal Katz， 爱思唯尔生命科学解决方案市场总监
12:20-12:30
Q&A Discussion
12:30-13:30
Lunch 午餐
13:30-14:10
Targeting protein-protein interactions (PPI) in drug discovery: An Ascentage journey
针对蛋白-蛋白相互作用的药物发现—亚盛医药
Dr. Guozhi TANG, VP of Discovery, Ascentage Pharma
唐国志博士，亚盛医药 药物发现副总经理
14:10-14:50
AI in Healthcare
医疗产业中的人工智能应用
Mr. Gordon ZHANG, Sr. Knowledge Mgt Manager, Novartis
张歌先生，诺华（中国）生物医学研究中心 高级经理
14:50-15:10
Beyond Chemical Drawing: ChemDraw 18 featuring Elsevier Reaxys.
超越化学结构绘制：ChemDraw 18介绍
Dr. Pierre Morieux, ChemDraw Global Mktg Mgr, Perkin Elmer
Pierre Morieux博士， 珀金埃尔默，ChemDraw全球市场经理
15:10-15:25
Q&A Discussion
15:25-15:40
Tea Break 茶歇
15:40-16:20
Big data analysis of animal-human concordance
大数据解密动物/人的药物毒理学一致性分析
Dr. Matt Clark, Director, Scientific Services, Elsevier
Matthew Clark博士, 爱思唯尔 科学服务总监
16:20-17:20
Panel Discussion：
圆桌讨论
Host: Mr. Genan ZHAO, General Manager, Research Solutions, Elsevier China
主持人： 赵歌喃先生, 爱思唯尔中国区科技部总经理
17:20-17:30
Closing 闭幕致辞
报名方式
本次论坛将以邀请方式报名，请将您的“公司名称、姓名、 职务、 联系电话、 Email”，发送至会务邮箱rdconnectevent@elsevier.com，以便我们给您发送邀请函。名额有限，敬请提前预约席位。
扫描下方二维码
进入论坛官网
爱思唯尔是一家全球专业从事科学与医学的信息分析公司。爱思唯尔的研发解决方案集成数据、分析和技术，帮助您做出数据驱动的药物发现和开发决策，并简化药物警戒的文献监控。我们的制药与生命科学解决方案——Reaxys、ScienceDirect、Scopus、Embase、QUOSAPV、PharmaPendium和ProfessionalServices，均由爱思唯尔在数据、科学和技术领域的独特且深厚专业知识提供支持。
亚盛医药是一家全球领先的处于临床阶段的新药研发企业，致力于在肿瘤、乙肝及与衰老相关的疾病等治疗领域开发创新药物。公司拥有自主研发的蛋白-蛋白相互作用靶向药物设计平台及100多项国际发明专利。公司研发产品管线主要专注细胞凋亡路径关键蛋白的抑制剂，通过抑制BCL-2、IAP或MDM2-p53等，重启肿瘤细胞的凋亡程序；第二代和第三代的针对癌症治疗中出现的激酶突变体的抑制剂；与肿瘤治疗有密切相关性的表观遗传学靶点的抑制剂等。公司现有7个新药项目已进入到中国、美国及澳大利亚的I-II期临床开发阶段。